Poster Presentation 37th Lorne Cancer Conference 2025

A clinically approved copper chelator in combination with standard-of-care chemotherapy reduces tumour desmoplasia and metastasis in PDAC (#215)

Ellie T.Y. Mok 1 2 , Yordanos F.I. Setargew 1 , Joanna N. Skhinas 1 , Michelle Yam 1 , Ron Enriquez 1 , Emmi Tran 1 , Dasol Yoo 1 , Céline Schmitter 1 3 , Sipiththa Velayuthar 1 , Kaitlin Wyllie 1 2 , Jessica L. Chitty 1 2 , Thomas R. Cox 1 2
  1. Cancer Ecosystems Program, The Garvan Institute of Medical Research & the Kinghorn Cancer Centre, Sydney, NSW, Australia
  2. School of Clinical Medicine, St Vincent’s Healthcare Clinical Campus, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW, Australia
  3. Current Address: Biology Department, École Normale Supérieure of Lyon, Claude Bernard Lyon 1 University, University of Lyon, Lyon, France
Publish consent withheld